Immunoglobulin Use In Pediatric Patients With RSV-Associated Lower Respiratory Tract Infections Has Little To No Effect On Hospitalization Length, Adverse Event Risk, Study Finds
November 10, 2023
Infectious Disease Advisor (11/9, Wei) reports, “The use of immunoglobulins in pediatric patients with respiratory syncytial virus (RSV)-associated lower respiratory tract infections (LRTIs) has little to no effect on hospitalization length and adverse ev...